Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Capital Expenditures (2019)

Historic Capital Expenditures for Traws Pharma (TRAW) over the last 4 years, with Q4 2019 value amounting to -$1000.0.

  • Traws Pharma's Capital Expenditures changed N/A to -$1000.0 in Q4 2019 from the same period last year, while for Dec 2023 it was -$1000.0, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 2595714.29% up from last year.
  • As of Q4 2019, Traws Pharma's Capital Expenditures stood at -$1000.0.
  • Traws Pharma's 5-year Capital Expenditures high stood at -$1000.0 for Q4 2019, and its period low was -$1000.0 during Q4 2019.